Connable Office Inc Emergent Bio Solutions Inc. Transaction History

Connable Office Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$27.42 - $43.63 $175,734 - $279,624	-6,409 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$36.48 - $52.22 $233,800 - $334,677	6,409 New	6,409 $263,000
Q4 2021 Feb 14, 2022	SELL	$33.11 - $55.01 $202,699 - $336,771	-6,122 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$50.07 - $66.05 $87,071 - $114,860	1,739 Added 39.68%	6,122 $307,000
Q1 2021 May 07, 2021	SELL	$86.23 - $125.19 $23,023 - $33,425	-267 Reduced 5.74%	4,383 $407,000
Q4 2020 Feb 09, 2021	SELL	$79.17 - $111.47 $22,721 - $31,991	-287 Reduced 5.81%	4,650 $417,000
Q3 2020 Nov 10, 2020	SELL	$81.91 - $134.94 $397,345 - $654,593	-4,851 Reduced 49.56%	4,937 $510,000
Q2 2020 Aug 10, 2020	BUY	$54.33 - $89.52 $54,818 - $90,325	1,009 Added 11.49%	9,788 $774,000
Q1 2020 May 08, 2020	BUY	$49.34 - $68.76 $160,453 - $223,607	3,252 Added 58.84%	8,779 $508,000
Q3 2019 Nov 12, 2019	BUY	$40.6 - $57.2 $4,425 - $6,234	109 Added 2.01%	5,527 $289,000
Q2 2019 Aug 06, 2019	BUY	$39.92 - $53.86 $216,286 - $291,813	5,418 New	5,418 $262,000

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $404M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Connable Office Inc, based on Form 13F filings with the SEC.

Stay updated on Connable Office Inc with notifications on news.